IP Library Granted Patent US 11,426,442
Granted Patent B2
US 11,426,442 · App. 16/870,643 · Granted Aug 30, 2022

Compositions and methods for invasive and non-invasive procedural skincare

Inventors: John A. Garruto (Encinitas, CA); Alan David Widgerow (Irvine, CA)
Assignee: ALASTIN SKINCARE, INC.
A61K38/08A61K8/26A61K8/37A61K8/416A61K8/42A61K8/498A61K8/4973A61K8/553A61K8/585A61K8/602A61K8/64A61K8/891A61K8/894A61K8/97A61K9/0014A61K31/01A61K31/047A61K31/16A61K31/231A61K31/353A61K31/47A61K31/685A61K31/695A61K31/7048A61K31/74A61K36/05A61K36/28A61K38/06A61K47/14A61K47/186A61K47/22A61K47/24A61K47/34A61Q19/00A61Q19/08A61K2300/00A61K2800/594A61K2800/5922A61K2800/75A61K2800/884
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,426,442
App. No.
16/870,643
Granted
Aug 30, 2022
Kind
B2
Abstract

Compositions and methods for skincare treatment are provided. The invention relates more generally to skin care treatment and more particularly, to compositions and methods for promoting healthy skin, skin regeneration, skin repair, skin bed preparation, and enhanced wound healing.

Claims (14)

1. A topical composition for promoting skin restoration around an eye, comprising:

a tripeptide-1 present at 1-10 ppm;

one or more peptides selected from a dipeptide, a tripeptide, or a tetrapeptide;

a hexapeptide-12 present at 1-10 ppm; and

Squalene,

wherein the topical composition is configured to promote restoration of damaged skin or aging skin around the eye.

2. The topical composition of claim 1 , wherein the tripeptide-1 comprises palmitoyl tripeptide-1, myristoyl tripeptide-1, or a combination thereof.

3. The topical composition of claim 1 , wherein the hexapeptide-12 comprises palmitoyl hexapeptide-12, myristoyl hexapeptide-12, or a combination thereof.

4. The topical composition of claim 1 , wherein the Squalene is present at 0.01-5.0 wt. %.

5. The topical composition of claim 1 , wherein the Squalene is present at 0.1-1.0 wt. %.

6. The topical composition of claim 1 , wherein the Squalene is present at no more than 1.0 wt. %.

7. The topical composition of claim 1 , wherein the Squalene is present at 0.25 wt. %.

8. The topical composition of claim 1 , further comprising one or more additional ingredients selected from the group consisting of disodium EDTA, niacinamide, caprylyl glycol, caprylhydroxamic acid, glycerin, phenoxyethanol, ethylhexylglycerin, betaine, propanediol, phospholipids, isopropyl palmitate, polyacrylate-13, polysorbate 20, Dunaliella salina extract, phytosterols, hydrolyzed pea protein, Butyrospermum parkii (Shea) butter, ceramide NP, tocopherol, butylene glycol, caprylyl methicone, ascorbyl palmitate, or combinations thereof.

9. The topical composition of claim 1 , wherein the composition is aqueous.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2020
From: GARRUTO, JOHN A.; WIDGEROW, ALAN DAVID
To: ALASTIN SKINCARE, INC.
Reel/Frame 053677/0838 →
Continuity (6)
Continuation 16293467 · Mar 5, 2019
Continuation 16004259 · Jun 8, 2018
Continuation 15423530 · Feb 2, 2017
Provisional Application 62303332 · Mar 3, 2016
Provisional Application 62291376 · Feb 4, 2016
Related Publication 20200338154A1 · Oct 29, 2020